We've added over 125 new datasets to our Cancer Model Database. It provides access to a comprehensive collection of well-established tumor models for early-stage oncology research and increases their translational capabilities to the clinic.
The update adds new patient-derived xenograft (PDX) models for several cancer types, including anal, colon, kidney, renal, and leukemia. Additionally, this update provides an increased depth of data for both whole exome sequencing (WES) and gene expression with greater coverage on bioinformatics data.
Our database allows researchers to easily identify the most appropriate tumor models, leading to a more targeted study from the outset, which saves time and money along the drug development pathway. When combined with our robust portfolio of oncology services and experienced scientific background, our database is a powerful, translational tool for developing safe, effective oncology therapeutics.
For more information, read our press release on the update.